Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
McKinsey
AstraZeneca
Johnson and Johnson
Dow

Last Updated: October 7, 2022

ACTINEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Actinex, and when can generic versions of Actinex launch?

Actinex is a drug marketed by Univ Az Cancer Ctr and is included in one NDA.

The generic ingredient in ACTINEX is masoprocol. There is one drug master file entry for this compound. Additional details are available on the masoprocol profile page.

US Patents and Regulatory Information for ACTINEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ACTINEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 See Plans and Pricing See Plans and Pricing
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ACTINEX

See the table below for patents covering ACTINEX around the world.

Country Patent Number Title Estimated Expiration
Australia 6930591 See Plans and Pricing
South Africa 8803957 See Plans and Pricing
Japan H01501794 See Plans and Pricing
Spain 2020011 METODO DE SINTESIS DE COMPOSICIONES QUE COMPRENDEN AL MENOS UN BUTANO FENOLICO. (Pharmaceutical compositions comprising catecholic butanes.) See Plans and Pricing
World Intellectual Property Organization (WIPO) 8706829 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.